Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc.
AGIO
Valuace
70
Růst
0
Zdraví
75
Cena
$ 41.46
Dnes
--0.61 (-2.19%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
2.4B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
0%
ROA
0%
PE
-4
PS
30
Cena 1R
22-46
⌀ Cena
34.06
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
12-02-2026
Poslední dividenda

Profil

Agios Pharmaceuticals, Inc., biofarmaceutická společnost, se zabývá objevováním a vývojem léčiv v oblasti buněčného metabolismu a přilehlých oblastech biologie. Společnost nabízí PYRUKYND (mitapivat) aktivátor jak divokého typu, tak různých mutantů pyruvát kinázy, PK, enzymů pro léčbu hemolytických anémií; a AG-946, který je ve fázi I klinické studie pro léčbu hemolytických anémií a dalších indikací. Společnost Agios Pharmaceuticals, Inc. byla založena v roce 2007 a sídlí v Cambridge v Massachusetts.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
486
Založení
2013-07-24
Adresa
88 Sidney Street
CEO
Brian M. Goff

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 202520242023202220212020201920182017201620152014201320122011
Total Revenues54.054.036.526.814.20.0203.2117.994.443.069.959.165.425.525.121.8
Cost of Revenues6.36.34.29.51.70.02.81.31.40.00.00.00.00.00.00.0
Gross Profit47.747.732.317.312.50.0200.4116.693.043.069.959.165.425.525.121.8
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues20.012.912.58.710.79.08.68.27.17.4
Cost of Revenues0.61.73.01.11.30.83.12.02.00.6
Gross Profit19.311.29.57.69.58.25.56.25.16.8
Operating Income TTM 202520242023202220212020201920182017201620152014201320122011
R&D Expenses0.00.00.0288.9279.9257.0367.5410.9341.3292.7220.2141.8100.454.541.031.3
Selling General & Admin Expenses0.00.00.0119.9121.7121.4149.1132.0114.171.150.736.019.19.97.17.2
Depreciation & Amortization5.25.25.76.6-137.7-6.66.68.17.26.45.73.31.41.41.20.8
Total Operating Expenses519.8519.8458.1408.8401.6378.4516.5542.9455.5363.8270.9177.8119.564.448.138.5
Operating Income-472.1-472.1-425.7-391.5-389.0-378.4-316.1-426.3-362.5-320.8-201.0-118.7-54.1-38.9-23.0-16.6
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.076.181.8
Selling General & Admin Expenses0.00.00.00.00.00.00.00.035.325.8
Depreciation & Amortization1.31.41.31.31.41.31.61.31.41.6
Total Operating Expenses140.9128.1136.6114.3134.5111.0111.398.3111.4107.7
Operating Income-121.6-116.9-127.1-106.6-125.0-102.8-105.8-92.1-106.3-100.9
Net Income TTM 202520242023202220212020201920182017201620152014201320122011
Interest Income56.456.448.133.312.80.86.614.916.56.12.51.00.20.10.10.1
Interest Expense0.00.00.00.012.80.017.80.016.56.12.51.00.20.10.10.1
Other Expense58.358.31,143.739.4157.221.9-11.214.916.56.12.51.00.20.10.10.1
IBT-413.8-413.8718.0-352.1-231.8-356.5-327.4-411.5-346.0-314.7-198.5-117.7-53.9-38.8-22.9-16.5
Income Tax Expense-1.0-1.044.20.0-157.2-1,977.97.8-14.932.9-6.4-5.7-0.4-0.40.6-2.87.2
Net Income-412.8-412.8673.7-352.1-74.61,604.7-335.2-396.6-346.0-314.7-198.5-117.7-53.5-39.4-20.1-23.7
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income12.413.414.516.118.013.18.18.98.68.4
Interest Expense0.00.00.00.00.00.00.00.00.00.0
Other Expense12.513.415.017.319.61,103.89.710.510.39.6
IBT-109.1-103.4-112.0-89.3-105.41,001.0-96.1-81.5-95.9-91.3
Income Tax Expense-1.00.00.00.0-8.953.10.00.01.4-10.0
Net Income-108.0-103.4-112.0-89.3-96.5947.9-96.1-81.5-95.9-91.3
Per Share Data TTM 202520242023202220212020201920182017201620152014201320122011
EPS$0.00$0.00$0.00$-6.33$-1.36$26.55$-4.86$-6.61$-6.03$-6.75$-5.07$-3.15$-1.59$-2.56$-0.86$-1.01
EPS Diluted$0.00$0.00$0.00$-6.33$-1.36$26.55$-4.86$-6.61$-6.03$-6.75$-5.07$-3.15$-1.59$-2.56$-0.86$-1.01
Shares Outstanding58.358.056.855.754.860.469.060.057.446.639.137.433.715.423.423.4
Diluted Shares Outstanding58.358.057.955.754.860.469.060.057.446.639.137.433.715.423.423.4
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-1.72$-1.64
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-1.72$-1.64
Shares Outstanding58.358.157.957.557.256.956.856.455.955.8
Diluted Shares Outstanding58.358.157.957.557.258.456.856.455.955.8
Current Assets TTM 20242023202220212020201920182017201620152014201320122011
Cash And Equivalents84.576.288.2139.3203.1127.480.9805.4567.8573.6375.914.071.691.3117.7
Short Term Investments485.4817.5688.7643.9816.9445.5483.9514.8321.2380.6245.2328.095.236.761.5
Total Cash & ST Investments569.9893.7776.91,097.01,286.4670.5564.9805.4567.8573.6375.9342.1166.8128.0179.2
Accounts Receivable3.84.12.82.24.425.415.310.43.88.311.612.70.50.00.0
Inventory23.927.619.18.516.214.77.30.9-143.8-32.3-58.90.00.00.00.0
Other Current Assets34.540.235.039.011.8-74.024.217.217.510.38.74.82.52.211.4
Total Current Assets632.1965.6833.8832.81,064.2636.7611.7613.8445.3559.9337.3359.5169.7130.1190.6
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents92.780.979.076.2253.784.5118.888.264.384.8
Short Term Investments860.2858.1814.4817.5751.0485.4479.2688.7583.2617.8
Total Cash & ST Investments952.9938.9893.4893.71,004.8569.9598.0776.9872.4946.9
Accounts Receivable5.05.03.34.13.13.83.52.81.22.3
Inventory32.030.829.627.626.423.923.119.117.315.7
Other Current Assets43.244.742.340.239.934.539.135.038.436.8
Total Current Assets1,033.11,019.5968.6965.61,074.2632.1663.6833.8704.4757.2
Long-Term Assets TTM 20242023202220212020201920182017201620152014201320122011
Net Property, Plant & Equipment61.554.669.888.1104.2117.5126.124.324.425.323.26.43.83.63.2
Goodwill0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Long-Term Investments75.4638.329.4313.9266.497.6152.9220.1143.832.358.9125.427.10.00.0
Other Long-Term Assets4.14.74.14.02.91.10.00.20.91.60.60.60.60.60.6
Total Long-Term Assets140.9697.6103.3405.9373.5216.3279.0244.7169.159.282.7132.431.56.93.9
Total Assets773.11,663.2937.11,238.71,437.7853.0890.7858.5614.4619.1420.1491.9201.2137.0194.5
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment44.347.450.954.657.761.565.769.873.979.5
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.0
Long-Term Investments304.3400.5531.3638.3655.975.4116.329.4224.9244.4
Other Long-Term Assets3.93.94.74.74.14.14.14.14.14.1
Total Long-Term Assets352.6451.8586.9697.6717.6140.9186.1103.3302.9327.9
Total Assets1,385.71,471.21,555.51,663.21,791.8773.1849.7937.11,007.31,085.2
Current Liabilities TTM 20242023202220212020201920182017201620152014201320122011
Accounts Payable10.016.69.818.616.726.821.917.922.817.114.711.13.73.33.6
Short-Term Debt15.916.830.013.711.27.46.9-59.8-125.8-154.3-4.714.38.26.719.5
Other Current Liabilities36.746.928.230.432.060.153.142.934.335.418.50.00.00.10.1
Current Liabilities62.681.268.062.659.894.492.993.594.988.452.961.136.935.148.2
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable19.617.513.716.617.110.011.29.813.311.6
Short-Term Debt18.017.617.216.816.315.915.430.029.328.7
Other Current Liabilities37.235.320.846.933.336.725.128.215.814.9
Current Liabilities74.870.452.481.2119.562.651.768.058.455.1
Long-Term Liabilities TTM 20242023202220212020201920182017201620152014201320122011
Long-Term Debt48.840.2114.072.085.997.8106.70.00.00.00.00.00.00.00.0
Capital Leases48.857.072.085.797.1105.2113.70.00.00.00.00.00.00.00.0
Def. Tax Liability0.00.00.00.00.0-261.30.00.00.00.00.00.00.00.00.0
Total Liabilities112.6122.2126.1137.9145.8453.5250.2170.9238.9260.574.967.569.793.1131.3
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt26.531.235.740.244.548.852.9114.0121.7129.2
Capital Leases44.548.852.957.060.864.668.357.075.578.9
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities101.4101.789.0122.2165.1112.6105.8126.1120.4120.9
Total Common Equity TTM 20242023202220212020201920182017201620152014201320122011
Common Stock0.10.10.10.10.10.10.10.10.00.00.00.00.00.00.0
Retained Earnings-1,000.3-148.9-822.6-470.6-238.8-1,843.5-1,516.1-1,104.6-798.1-483.2-284.7-166.9-113.4-74.0-53.9
Comprehensive Income-1.0-1.5-0.4-12.5-1.20.10.2-2.2-1.4-0.3-0.3-0.10.00.00.0
Total Common Equity660.51,541.0811.01,100.81,292.0399.5640.5687.5375.5358.6345.1424.4131.543.963.1
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.10.10.10.10.10.10.10.10.10.1
Retained Earnings-453.7-350.2-238.2-148.9-52.4-1,000.3-904.2-822.6-726.7-635.4
Comprehensive Income2.10.70.4-1.53.4-1.0-1.1-0.4-5.9-8.9
Total Common Equity1,284.31,369.61,466.51,541.01,626.7660.5743.9811.0886.8964.2
Other TTM 20242023202220212020201920182017201620152014201320122011
Total Debt64.657.072.085.797.1105.2113.70.00.00.00.00.00.00.00.0
Book Value660.51,541.0811.01,100.81,292.0399.5640.5687.5375.5358.6345.1424.4131.543.963.1
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value1,284.31,369.61,466.51,541.01,626.7660.5743.9811.0886.8964.2
Cash Flow From Operating Activities TTM 202520242023202220212020201920182017201620152014201320122011
Net Income-364.9-412.8673.7-352.1-231.8-356.5-327.4-411.5-346.0-314.7-198.5-117.7-53.5-39.4-20.1-23.7
Depreciation & Amortization6.05.25.76.68.69.210.08.17.26.45.73.31.41.41.20.8
Stock-Based Compensation43.752.642.844.849.353.575.172.473.447.842.132.011.53.00.70.4
Change Working Capital-16.0-33.0-19.8-19.1-16.4-36.8-71.0-46.0-35.1-24.8188.54.9-19.3-25.6-38.417.6
Change In Accounts Receivable-1.5-6.5-1.3-0.6-2.20.0-10.1-3.6-6.11.23.3-1.7-6.00.00.00.0
Change In Accounts Payable-1.61.76.6-8.73.41.95.93.7-5.55.33.54.27.60.0-0.30.8
Change In Inventories-8.3-5.3-8.5-10.6-8.50.0-7.4-6.5-0.9-2.114.4-3.20.00.00.00.0
Other Non-cash Items79.015.1-1,092.323.7-119.19.519.58.5-3.80.00.80.60.50.30.30.4
Cash from Operations-306.60.00.0-296.1-309.5-407.3-290.8-370.6-304.4-285.238.6-76.9-59.4-56.4-49.5-15.2
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-108.0-103.4-112.0-89.3-96.5947.9-96.1-81.5-95.9-91.3
Depreciation & Amortization1.31.41.31.31.41.31.61.31.41.6
Stock-Based Compensation14.112.414.711.410.911.111.69.213.89.1
Change Working Capital-4.6-0.28.3-36.5-46.345.410.1-29.05.6-2.7
Change In Accounts Receivable-5.50.0-1.60.8-1.00.6-0.3-0.6-1.61.1
Change In Accounts Payable-1.11.83.9-2.8-0.87.1-1.21.4-3.51.6
Change In Inventories-0.9-1.2-1.2-2.0-1.2-2.5-0.9-4.0-1.8-1.6
Other Non-cash Items1.01.810.71.7-2.7-1,090.00.20.126.220.2
Cash from Operations0.00.00.00.00.00.00.00.0-72.5-61.6
Cash Flow From Investing Activities TTM 202520242023202220212020201920182017201620152014201320122011
Capital Expenditure-18.4-4.3-1.7-1.0-4.9-5.7-14.9-12.2-7.0-4.6-9.9-20.2-2.2-1.3-1.5-1.9
Acquisitions17.50.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Investments-534.0-641.8-1,542.4-417.9-1,030.8-1,378.2-557.0-488.6-933.3-688.7-506.1-353.2-837.2-146.0-88.5-105.9
Sales of Investment847.91,033.3818.4674.71,146.2829.8647.7592.2666.5635.4396.6501.7505.560.1113.085.5
Other Investing Activities116.90.00.0-16.2132.71,802.90.00.00.00.00.00.00.60.00.00.0
Cash from Investing296.70.00.0239.6243.31,248.875.791.4-273.8-57.9-119.4128.3-333.3-87.223.0-22.4
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-1.1-1.6-0.9-0.8-1.0-0.4-0.2-0.1-0.2-17.9
Acquisitions0.00.00.00.00.00.00.00.00.017.5
Investments-161.1-175.0-130.8-174.9-198.3-995.5-104.5-244.1-90.4-95.0
Sales of Investment252.3272.1220.6288.3150.1157.6141.9368.7186.2151.0
Other Investing Activities0.00.00.00.00.00.00.00.095.7-16.3
Cash from Investing0.00.00.00.00.00.00.00.095.539.3
Cash Flow From Financing Activities TTM 202520242023202220212020201920182017201620152014201320122011
Debt Repaid0.00.00.00.0-0.3-0.6-0.3-0.10.00.00.00.00.00.00.00.0
Debt Issued-14.357.0-15.0-13.7-11.1-7.5-8.1113.80.00.00.00.00.00.00.00.0
Issuance of Common Stock9.70.00.05.40.00.00.0277.2516.2270.3162.20.0333.6126.10.00.0
Repurchase of Common Stock0.00.00.00.00.0-802.50.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities9.70.00.05.42.737.3261.912.529.814.97.66.41.6-2.20.177.4
Cash from Financing9.70.00.05.42.4-765.8261.5289.6546.0285.1169.86.4335.2123.90.177.4
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued44.5-4.2-4.2-4.0-3.8-3.8-3.7-3.6-3.5-3.4
Issuance of Common Stock0.00.00.00.00.00.00.00.00.81.9
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.81.9
Cash from Financing0.00.00.00.00.00.00.00.00.81.9
Cash position TTM 202520242023202220212020201920182017201620152014201320122011
Net Change in Cash-0.212.9-12.0-51.1-63.975.746.510.4-32.2-58.089.057.7-57.5-19.7-26.439.8
Closing Cash Balance84.589.176.288.2139.3203.1127.480.970.5102.7160.871.814.071.691.3117.7
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-3.611.81.92.7-177.5169.2-34.230.623.9-20.4
Closing Cash Balance89.192.780.979.076.2253.784.5118.888.264.3
Free Cash Flow TTM 202520242023202220212020201920182017201620152014201320122011
Free Cash Flow-325.0-377.3-391.5-297.1-314.4-413.1-305.7-382.8-311.4-289.928.6-97.1-61.6-57.7-51.0-17.1
Real Free Cash Flow-368.7-429.8-434.4-341.8-363.7-466.6-380.8-455.2-384.8-337.7-13.4-129.1-73.1-60.7-51.8-17.5
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-97.3-89.7-78.0-112.3-134.1-84.6-72.7-100.0-72.7-79.5
Real Free Cash Flow-111.5-102.1-92.7-123.6-145.0-95.8-84.3-109.2-86.5-88.6
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-3.9-15.6-1.4
P/S30.150.89.4
P/B1.35.25.2
P/FCF-3.8-6.7-1.5
Market cap$2.4$2.1
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %3.9 %0 %
Debt to Income-10.8 %-14.8 %0 %
Debt to Free cash flow-10.4 %-247.5 %0 %
Interest expense percentage0 %-1.5 %44.7 %
Current ratio13.8 9.5 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-32.1 %-24.1 %0 %
ROA-29.8 %-13.4 %0 %
CapEx to Revenue8 %18.1 %0 %
RaD to Revenue0 %566.9 %0 %
ROEM111,168.7 176108.6

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin88.3 %95.4 %68.7 %
Operating margin-873.9 %-731.3 %35.5 %
Net margin-764 %-239.4 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding58.3 mil 48.6 mil
Employee count0.5 tis 0.4 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader